Trupanion, Inc. logo TRUP - Trupanion, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 7
SELL 0
STRONG
SELL
0
| PRICE TARGET: $34.25 DETAILS
HIGH: $42.00
LOW: $29.00
MEDIAN: $33.00
CONSENSUS: $34.25
UPSIDE: 38.78%

Stock News

Head-To-Head Review: Corebridge Financial (NYSE:CRBG) versus Trupanion (NASDAQ:TRUP)

Head-To-Head Review: Corebridge Financial (NYSE:CRBG) versus Trupanion (NASDAQ:TRUP)

Trupanion (NASDAQ: TRUP - Get Free Report) and Corebridge Financial (NYSE: CRBG - Get Free Report) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations. Earnings and Valuation This table compares Trupanion and Corebridge

Sep 29, 2026 02:15 AM • defenseworld.net
Trupanion: Profitable At Last, But Still Too Expensive To Buy (Upgrade)

Trupanion: Profitable At Last, But Still Too Expensive To Buy (Upgrade)

Trupanion's estimated economic combined ratio improved to 98.5% in H1 2026, extending the underwriting profitability first achieved in 2025. Operating leverage and lower acquisition costs drove much of the improvement, while the H1 loss ratio also declined to 71.0% from 72.1%. Management's 2026 guidance could imply $32–$40 million of net income, providing stronger evidence that scale is finally translating into profitability.

Aug 14, 2026 01:12 AM • seekingalpha.com
Trupanion Reports Second Quarter 2026 Results

Trupanion Reports Second Quarter 2026 Results

SEATTLE, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended June 30, 2026. “We continue to execute on the priorities that matter most by growing margin, improving the economics of new enrollments, and investing our capital with discipline,” said Margi Tooth, Chief Executive Officer and President of Trupanion.

Aug 05, 2026 12:05 PM • globenewswire.com

Price Targets